Genomic Health, BioServe, Seegene, Gene Logic, Abbott | GenomeWeb
Genomic Health to Sell 3 Million Shares
Genomic Health plans to sell 3 million shares of its common stock through an underwritten public offering, the company said this week.
The company said it will use the proceeds from the sale for general corporate purposes, marketing, R&D, and for expanding its labs.
Genomic Health said it will grant underwriters a 30-day option to buy an additional 450,000 shares.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.